Literature DB >> 8330138

Nasopharyngeal carcinoma: local control by megavoltage irradiation.

A W Lee1, S C Law, W Foo, Y F Poon, D K Chan, S K O, S Y Tung, F K Cheung, M Thaw, J H Ho.   

Abstract

This is a retrospective analysis of the long-term local control in 4128 patients with non-disseminated nasopharyngeal carcinoma treated solely by megavoltage irradiation during the years 1976-1985. The T-stage distribution according to Ho's classification was T1 37%, T2 14% and T3 49%. Different fractionation schedules had been employed at different periods, and the median dose to the primary target was equivalent to 65 Gy by time dose fractionation calculation. In 8% (344) of patients the tumour failed to regress completely after the basic course, but 89% (148/167) of those suitable for salvage with additional irradiation eventually attained complete local remission. The cumulative incidence of local failure was 24% (5% persistence, 19% recurrence). The 10-year actuarial local failure-free survival was 67%. While patients with T2 and T3a tumours achieved local control comparable to T1, those with T3c-d had the poorest control (with highest incidence of persistence and advanced recurrence). T-stage adjusted analyses suggested a significant trend of dose-response: the odds ratios for local failure were 1.16 and 1.86, respectively, when patients given 60-63 Gy and 55-59 Gy were compared with those given 64 Gy or above (p value = 0.0018). Patients treated during 1981-1985 achieved higher local failure-free survival than those treated during 1976-1980 (75% versus 70% at 5 years, p value = 0.0013). The possible attributes are studied, and ways for future optimization of treatment discussed.

Entities:  

Mesh:

Year:  1993        PMID: 8330138     DOI: 10.1259/0007-1285-66-786-528

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  12 in total

Review 1.  Acute hemorrhage in late radiation necrosis of the temporal lobe: report of five cases and review of the literature.

Authors:  K M Cheng; C M Chan; Y T Fu; L C Ho; F C Cheung; C K Law
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

2.  Temporal lobe injury after re-irradiation of locally recurrent nasopharyngeal carcinoma using intensity modulated radiotherapy: clinical characteristics and prognostic factors.

Authors:  Shuai Liu; Taixiang Lu; Chong Zhao; Jingxian Shen; Yunming Tian; Ying Guan; Lei Zeng; Weiwei Xiao; Shaomin Huang; Fei Han
Journal:  J Neurooncol       Date:  2014-07-02       Impact factor: 4.130

Review 3.  Contribution of radiotherapy to function preservation and cancer outcome in primary treatment of nasopharyngeal carcinoma.

Authors:  Anne W M Lee
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

4.  [Treatment results of nasopharyngeal carcinoma in adults].

Authors:  M Jakob; M Manz; S Herberhold; A Schröck; A O H Gerstner; H Schüller; K W G Eichhorn
Journal:  HNO       Date:  2012-12       Impact factor: 1.284

5.  Paediatric nasopharyngeal carcinoma: an 8-year study from a tertiary care cancer centre in South India.

Authors:  B Guruprasad; P Tanvir; B Rohan; S Kavitha; Sudhir M Naik; L Appaji
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-02-09

6.  Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma: clinical outcomes and patterns of failure in an endemic area in China.

Authors:  Lei Zeng; Yun-Ming Tian; Xue-Ming Sun; Ying Huang; Chun-Yan Chen; Fei Han; Shuai Liu; Mei Lan; Ying Guan; Xiao-Wu Deng; Tai-Xiang Lu
Journal:  Strahlenther Onkol       Date:  2014-05-17       Impact factor: 3.621

Review 7.  Nasopharyngeal carcinoma: molecular biomarker discovery and progress.

Authors:  William Chi-Shing Cho
Journal:  Mol Cancer       Date:  2007-01-02       Impact factor: 27.401

8.  Diagnosis of post-radiotherapy local failures in nasopharyngeal carcinoma: a prospective institutional study.

Authors:  Puneet Kumar Bagri; Mukesh Kumar Singhal; Daleep Singh; Akhil Kapoor; Shankar Lal Jakhar; Neeti Sharma; Surender Beniwal; Harvindra Singh Kumar; Ajay Sharma; Megh Raj Bardia
Journal:  Iran J Cancer Prev       Date:  2014

Review 9.  Current treatment options for local residual nasopharyngeal carcinoma.

Authors:  S D Stoker; J N A van Diessen; J P de Boer; B Karakullukcu; C R Leemans; I B Tan
Journal:  Curr Treat Options Oncol       Date:  2013-12

10.  TEL2 suppresses metastasis by down-regulating SERPINE1 in nasopharyngeal carcinoma.

Authors:  Yi Sang; Ming-Yuan Chen; Donghua Luo; Ru-Hua Zhang; Li Wang; Mei Li; Rongzhen Luo; Chao-Nan Qian; Jian-Yong Shao; Yi-Xin Zeng; Tiebang Kang
Journal:  Oncotarget       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.